_version_ 1784695717739102208
author Felten, Renaud
Geoffroy, Marion
Bolko, Loïs
Duret, Pierre-Marie
Desmurs, Marie
Fan, Angélique
Couderc, Marion
Laurent, Messer
Ardizzone, Marc
Ahmed-Yahia, Samira
Javier, Rose-Marie
Meyer, Alain
Chatelus, Emmanuel
Sordet, Christelle
Pijnenburg, Luc
Sibilia, Jean
Soubrier, Martin
Gottenberg, Jacques-Eric
Salmon, Jean-Hugues
author_facet Felten, Renaud
Geoffroy, Marion
Bolko, Loïs
Duret, Pierre-Marie
Desmurs, Marie
Fan, Angélique
Couderc, Marion
Laurent, Messer
Ardizzone, Marc
Ahmed-Yahia, Samira
Javier, Rose-Marie
Meyer, Alain
Chatelus, Emmanuel
Sordet, Christelle
Pijnenburg, Luc
Sibilia, Jean
Soubrier, Martin
Gottenberg, Jacques-Eric
Salmon, Jean-Hugues
author_sort Felten, Renaud
collection PubMed
description
format Online
Article
Text
id pubmed-9047403
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société française de rhumatologie. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-90474032022-04-29 Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides Felten, Renaud Geoffroy, Marion Bolko, Loïs Duret, Pierre-Marie Desmurs, Marie Fan, Angélique Couderc, Marion Laurent, Messer Ardizzone, Marc Ahmed-Yahia, Samira Javier, Rose-Marie Meyer, Alain Chatelus, Emmanuel Sordet, Christelle Pijnenburg, Luc Sibilia, Jean Soubrier, Martin Gottenberg, Jacques-Eric Salmon, Jean-Hugues Joint Bone Spine Letter to the Editor Société française de rhumatologie. Published by Elsevier Masson SAS. 2022-10 2022-04-28 /pmc/articles/PMC9047403/ /pubmed/35490948 http://dx.doi.org/10.1016/j.jbspin.2022.105391 Text en © 2022 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Felten, Renaud
Geoffroy, Marion
Bolko, Loïs
Duret, Pierre-Marie
Desmurs, Marie
Fan, Angélique
Couderc, Marion
Laurent, Messer
Ardizzone, Marc
Ahmed-Yahia, Samira
Javier, Rose-Marie
Meyer, Alain
Chatelus, Emmanuel
Sordet, Christelle
Pijnenburg, Luc
Sibilia, Jean
Soubrier, Martin
Gottenberg, Jacques-Eric
Salmon, Jean-Hugues
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title_full Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title_fullStr Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title_full_unstemmed Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title_short Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
title_sort different anti-sars-cov-2 vaccine response under b- and t-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047403/
https://www.ncbi.nlm.nih.gov/pubmed/35490948
http://dx.doi.org/10.1016/j.jbspin.2022.105391
work_keys_str_mv AT feltenrenaud differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT geoffroymarion differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT bolkolois differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT duretpierremarie differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT desmursmarie differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT fanangelique differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT coudercmarion differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT laurentmesser differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT ardizzonemarc differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT ahmedyahiasamira differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT javierrosemarie differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT meyeralain differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT chatelusemmanuel differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT sordetchristelle differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT pijnenburgluc differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT sibiliajean differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT soubriermartin differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT gottenbergjacqueseric differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides
AT salmonjeanhugues differentantisarscov2vaccineresponseunderbandtcelltargetedtherapiesversusanticytokinetherapiesinpatientswithinflammatoryarthritides